No Result

View All Result

Login

Shop
News
- Specials
- World Days – The overview
Excipient basics
Applications
Sources
Suppliers
Excipient Suppliers List

ADM

Antares

Armor Pharma

Asahi KASEI

Ashland

BASF

Beneo

Captisol

Clariant

Croda

DFE Pharma

Dow

Excipio Chemicals

Fuji Chemical

Gattefossé

Gangwal

Indovinya

Ingredient Pharm

IOI Oleo

JRS Pharma

KLK Oleo

Lipoid

Lubrizol Life Science Health

MAGNESIA

MEGGLE

Mingtai Chemical

Nagase Viita

Nordic Bioproducts

pharm-a-spheres

PMC Isochem

PQ

Seppic

ShinEtsu

Sigachi

SPI Pharma

Südzucker

Vikram Thermo

Zerion Pharma
Inquiries
- Product Inquiry
- Tailored Tableting Excipients
  - Tailored Film Coating
Events
All4Nutra

No products in the cart.

Shop
News
- Specials
- World Days – The overview
Excipient basics
Applications
Sources
Suppliers
Excipient Suppliers List

ADM

Antares

Armor Pharma

Asahi KASEI

Ashland

BASF

Beneo

Captisol

Clariant

Croda

DFE Pharma

Dow

Excipio Chemicals

Fuji Chemical

Gattefossé

Gangwal

Indovinya

Ingredient Pharm

IOI Oleo

JRS Pharma

KLK Oleo

Lipoid

Lubrizol Life Science Health

MAGNESIA

MEGGLE

Mingtai Chemical

Nagase Viita

Nordic Bioproducts

pharm-a-spheres

PMC Isochem

PQ

Seppic

ShinEtsu

Sigachi

SPI Pharma

Südzucker

Vikram Thermo

Zerion Pharma
Inquiries
- Product Inquiry
- Tailored Tableting Excipients
  - Tailored Film Coating
Events
All4Nutra

No Result

View All Result

No Result

View All Result

Startseite » Suppliers » Captisol » Page 9

Captisol

Captisol as Solubilizer

Comparison of Proprietary and 3 Generic Formulation of Propofol for Induction of General Anesthesia

8. November 2019

Background: This study compared the properties of propofol bolus for induction of general anesthesia between proprietary and 3 generic formulations,...

CNS penetration and pharmacodynamics of the CHK1 inhibitor prexasertib

CNS penetration and pharmacodynamics of the CHK1 inhibitor prexasertib in a mouse Group 3 medulloblastoma model

30. October 2019

Prexasertib (LY2606368) is a potent and selective small molecule inhibitor of cell-cycle checkpoint CHK1 and CHK2 protein kinases and is...

Pharmaceutical Drug Carrier

Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion

20. September 2019

Background Renal cell carcinomas (RCC) harboring a TFE3 gene fusion (TfRCC) represent an aggressive subset of kidney tumors. Key signaling pathways of...

Page 9 of 9 Prev 1 … 8 9

No Result

View All Result

About | Privacy Policy | Cookie policy | Cookie Settings | Contact | Homepage

Copyright: PharmaExcipients AG